GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS …

May 2, 2024 · GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). ... GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags. editorial ...

CouponFollow Extension

9%
OFF

GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS …

1 week from now

yahoo.com

8%
OFF

First Quarter 2024 - GSK

1 week from now

Core earnings per share Increase between 8% to 10% Increase between 6% to 9% GSK expects first half 2024 sales growth to be higher than second half 2024 due to the comparator to H2 …

gsk.com

$1.09
OFF

GSK Beats Q1 Earnings & Sales Estimates, Ups 2024 Guidance

1 week from now

May 1, 2024 · In This Article: GSK plc GSK reported core earnings of $1.09 per American depositary share (“ADS”) in first- quarter 2024, beating the Zacks Consensus Estimate of 94 …

yahoo.com

68%
OFF

Q1 2024 Results - GSK

1 week from now

• 68% market share in retail at the end of Q1 20241 • Majority of 2024 sales to be in the US, weighted to H2 • Launched in 24 markets to date • >£3bn in global peak year sales potential …

gsk.com

$1.09
OFF

GSK Stock Earnings: GSK Beats EPS, Beats Revenue For Q1 2024

1 week from now

May 1, 2024 · GSK (NYSE: GSK) just reported results for the first quarter of 2024.. GSK reported earnings per share of $1.09. This was above the analyst estimate for EPS of 91 cents. The …

investorplace.com

$1.09
OFF

GSK Stock Earnings: GSK Beats EPS, Beats Revenue For Q1 2024

1 week from now

May 1, 2024 · GSK (NYSE: GSK) just reported results for the first quarter of 2024. GSK reported earnings per share of $1.09. This was above the analyst estimate for EPS of 91 cents.

businessinsider.com

9%
OFF

GSK: Earnings Confirm It's On Track To Meet Guidance

1 week from now

Oct 30, 2024 · Summary. GSK is on track to achieve its guidance for 2024, with its Q3 2024 and 9m 2024 results today. For 9m 2024, the company's turnover growth at 9% is at the upper end …

seekingalpha.com

$9.19
OFF

GSK Lifts Guidance After Turnover Beats Expectations — Update

1 week from now

May 1, 2024 · GSK said it expects the majority of its sales of shingles vaccine Shingrix in China in the first half 2024. First-quarter turnover rose to 7.36 billion pounds ($9.19 billion) from …

morningstar.com

£7.88
OFF

GSK Lifts Profit And Sales Forecasts After Quarterly Beat - RTÉ

1 week from now

Jul 31, 2024 · GSK has today reported second-quarter core earnings per share (EPS) of 43.4 pence on sales of £7.88 billion. British drugmaker GSK has today raised its annual earnings …

rte.ie

8%
OFF

GSK EPS - Earnings Per Share 2010-2024 - Macrotrends

1 week from now

GSK 2021 annual EPS was $3.01, a 17.8% decline from 2020. GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many …

macrotrends.net

$1.29
OFF

GSK (NYSE:GSK) Stock, Earnings Estimates, EPS, And Revenue

1 week from now

GSK (GSK) is scheduled to report earnings on February 5, 2025. The last reported earnings were for reported on October 30, 2024 for Q3. The Actual EPS was $1.29, which beat the estimate …

benzinga.com

$2.26
OFF

CISCO REPORTS FIRST QUARTER EARNINGS

1 week from now

4 days ago · Earnings per Share: GAAP: $2.26 to $2.38; Non-GAAP: $3.60 to $3.66. Cisco today reported first quarter results for the period ended October 26, 2024. Cisco reported first …

cisco.com

41%
OFF

GSK Delivers Continued Strong Performance And Upgrades 2024 …

1 week from now

Jul 31, 2024 · Trelegy £0.8 billion +41%. Total operating profit -22% and Total EPS -27% for Q2 2024 primarily reflected higher charges for CCL (1) remeasurements driven by improved …

gsk.com

48%
OFF

GSK (GSK) Q3 Earnings Surpass Estimates - Yahoo Finance

1 week from now

Oct 30, 2024 · Glaxo (GSK) delivered earnings and revenue surprises of 9.48% and 2.16%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies …

yahoo.com

8%
OFF

Tesla (TSLA) Q3 2024 Earnings Report - CNBC

1 week from now

Oct 23, 2024 · Revenue: $25.18 billion vs. $25.37 billion expected. Revenue increased 8% in the quarter from $23.35 billion a year earlier. Net income rose to about $2.17 billion, or 62 cents a …

cnbc.com

2%
OFF

BeiGene (BGNE) Earnings Date And Reports 2024 - MarketBeat

1 week from now

2 days ago · Quarterly revenue rose 28.2% year-over-year to $1 billion, above analyst estimates of $983.26 million. With a trailing EPS of -$8.24, BeiGene's earnings are expected to grow …

marketbeat.com

$0.38
OFF

United Airlines Announces First-Quarter 2024 Financial Results; …

1 week from now

Apr 16, 2024 · United Airlines Announces First-Quarter 2024 Financial Results; Exceeds Revenue and EPS Expectations. First-quarter diluted loss per share of $0.38; first-quarter adjusted …

prnewswire.com

$0.15
OFF

America's Car-Mart (CRMT) Earnings Date And Reports 2024

1 week from now

2 days ago · America's Car-Mart issued Q1 2025 earnings on September 4, 2024, reporting an EPS of -$0.15, which missed analysts' consensus estimates of $0.66 by $0.81. Quarterly …

marketbeat.com

$22.57
OFF

Disney (DIS) Earnings Q4 2024 - CNBC

1 week from now

3 days ago · Revenue: $22.57 billion vs. $22.45 billion expected. Disney’s net income increased to $460 million, or 25 cents per share, from $264 million, or 14 cents per share, during the …

cnbc.com

3%
OFF

Fabrinet First Quarter 2025 Earnings: Revenues Beat Expectations, …

1 week from now

Nov 6, 2024 · Fabrinet Revenues Beat Expectations, EPS Falls Short. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 4.9%. Looking …

yahoo.com

62%
OFF

Mid-Morning Look: November 15, 2024 - Regal Discount Securities

1 week from now

2 days ago · Mid-Morning Look Friday, November 15, 2024 Index Up/Down % Last DJ Industrials -272.14 0.62% 43,478 S&P 500 -67.82 1.14% 5,881 Nasdaq -357.48 1.88% 18,748 Russell …

eregal.com

$0.62
OFF

La-Z-Boy (LZB) Earnings Date And Reports 2024 - MarketBeat

1 week from now

4 days ago · La-Z-Boy released Q1 2025 earnings on August 20, 2024, reporting an EPS of $0.62, which beat analysts' consensus estimates of $0.60 by $0.02. Quarterly revenue rose …

marketbeat.com

FAQs about GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS … Coupon?

How did GSK perform in Q1 2024?

In Q1 2024, GSK reported earnings of $1.09 per share, which was $0.15 higher than the consensus estimate of $0.94. The company generated $9.34 billion in revenue, which was $0.36 billion more than analysts' expectations of $8.98 billion. GSK last released its earnings results on May 1st, 2024. ...

How much will GSK (GSK) earn per share in 2024?

GSK's earnings are expected to grow by 9.98% in 2024, from $4.11 to $4.52 per share. The company's estimated earnings date is Wednesday, July 24th, 2024 based on prior year's report dates. ...

When is the next earnings release for GSK?

The estimated earnings release date for GSK is Wednesday, July 24th, 2024. GSK has not formally confirmed this date yet. Enter your email address below to receive the latest news and analysts' ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. ...

Will GSK pay dividends in Q1 2024?

The Board has declared a first interim dividend for Q1 2024 of 15p per share (Q1 2023: 14p per share). Dividends remain an essential component of total shareholder return and GSK recognises the importance of dividends to shareholders. ...

How much does GSK (GSK) earn per share?

GSK (GSK) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.26 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 9.48%. ...

What does total reported results mean for GSK?

Total reported results represent the Group’s overall performance. GSK has made one update to its reporting framework in Q1 2024 which is to change the description of Adjusted results to Core results to align with European peers in the pharmaceutical industry but with no change to the basis or figures. ...